Eicosanoids and radiation.
Eicosanoids and radiation.
复制标题
类二十烷酸和辐射。
DOI:
10.1016/0959-8049(95)00327-f
复制
发表时间:
1995
期刊:
影响因子:
--
通讯作者:
Hanson,WR
中科院分区:
文献类型:
--
作者:
Milas,L;Hanson,WR
THE MAXIMUM dose of radiation that can be given during radiotherapy depends on the tolerance of the critical normal tissue within the radiation field. Consequently, any attempt to improve the efficacy of radiotherapy must be aimed at increasing tumour radioresponse and/or reducing normal tissue complications. To achieve this objective, many diverse approaches have been investigated, including modulation of levels of eicosanoids, especially prostaglandins (PCs), in both normal tissues and tumours.Eicosanoids are produced in response to a variety of cellular injuries, and exogenous eicosanoids have been shown to modulate injury induced by a wide array of agents. Therefore, it was logical to infer their involvement in tissue injury by ionising radiation. During the past 20 years, there has been significant research into the role of eicosanoids, primarily PGs, in radiation damage. Attempts have been made to modulate normal tissue damage by administering exogenous PGs or inhibiting endogenous PGs. Other studies have been conducted to increase tumour response to radiation by modulating PG levels in tumours. This overview considers major fmdings on the role of eicosanoids in the expression and modification of radiation damage, with special emphasis on its therapeutic potential.